Clinical Trial Update: Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine. [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study evaluated immunogenicity at three dose levels of IMVAMUNE (MVA-BN) smallpox vaccine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• IMVAMUNE (MVA-BN) (MVA-BN)

Snippet

Sponsor: Bavarian Nordic | Conditions: Smallpox | Phase 2 | Status: COMPLETED